CIK 0001422142
- Non-accelerated filer
- Smaller reporting company
Whitehawk Therapeutics, Inc.
Sign in to watch- Ticker
- WHWK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547850
- Phone
- +1 551-321-2234
- Business address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
- 4 Open-market buy Director bought 63,818 shares at an average $2.35 ($150,290)
- 4 Open-market buy Director bought 60,000 shares at an average $2.12 ($127,462)
- 4 Open-market buy Director bought 60,000 shares at an average $1.80 ($108,110)
- 4 Open-market buy Director bought 60,000 shares at an average $1.74 ($104,134)
- 4 Open-market buy Director bought 60,000 shares at an average $1.92 ($115,224)
- 4 Open-market buy Director bought 60,000 shares at an average $2.02 ($121,340)
- 4 Open-market buy Director bought 60,000 shares at an average $2.12 ($127,242)
- 4 Open-market buy Director bought 60,000 shares at an average $2.09 ($125,352)
- 4 Open-market buy Director bought 60,000 shares at an average $1.98 ($118,524)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 31,967 shares at an average $2.01 ($64,136)
- 4 Returned to the company Director returned 1,603,526 shares (to the company)
- 4 Open-market sale 10% owner sold 5,300 shares at $3.90 ($20,670)
- 4 Open-market buy Director bought 777,500 shares at $3.85 ($2,993,375)
- 4 Open-market buy Director bought 777,500 shares at $3.85 ($2,993,375)
- 4 Open-market buy Director bought 1,818,182 shares at $3.85 ($7,000,001)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 14 · 263 filings